SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Intercept Pharmaceuticals Announces Positive Phase II Results for Obeticholic Acid (INT-747) as Monotherapy in Primary Biliary Cirrhosis